Novartis set to join forces with IBM Watson Health to tackle breast cancer.

The multinational pharmaceutical company and IBM Watson are teaming up in a “ground-breaking collaboration” that aims to combine machine learning with real-world data to improve outcomes in advanced breast cancer. Both parties are planning to explore development of a ‘cognitive solution’ that will provide improved insights on the potential outcomes of breast cancer treatment options,

Continue Reading